ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported financial results for the three months ended June 30, 2008. ISTA reported net revenue of $17.8 million for the quarter ended June 30, 2008, a 31% increase over the same quarter of 2007. The net loss for the second quarter ended June 30, 2008, was $8.5 million (or $0.26 per share), as compared with a net loss of $8.7 million (or $0.32 per share) for the same period in 2007.
\"Xibrom sales continued to grow strongly during the second quarter. As our commercial business grows, ISTA\'s presence in the ophthalmic community is further enhanced and physicians are excited about the products we plan to bring to them in the coming years,\" stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA Pharmaceuticals.
- Published: 08 August 2008
- Written by Editor